NCT06996275

Brief Summary

Post-traumatic stress disorder (PTSD) is a pathology that impairs the quality of life of sufferers. In military personnel, it can lead to military incapacity. This psychopathology is characterized by confrontation with one or more traumatic events in the individual's life history. Symptoms include cognitive and mood disorders, avoidance, hyperactivation (hypervigilance and anger) and intrusions (flashbacks and nightmares). Studies show that the prevalence of PTSD in military personnel fluctuates considerably from one situation to another (pre-deployment/post-deployment, etc.). In these at-risk populations, the often more complex PTSD clinic may also account for the heterogeneity of prevalences observed. Nevertheless, PTSD tends to become chronic in military personnel, making it particularly difficult to return to a "previous" state. In French casualties, beyond the symptoms already mentioned, complaints focus on difficulties in social interaction situations involving others in social life (attachment style to others) and in everyday life (public transport, supermarket shopping, social interactions, presence of crowds...). In the context of post-traumatic stress disorder, we would like to explore the processes of social cognition that enable people to interact in their environment, in relation to biological, psychosocial and physiological variables that may constitute risk or maintenance factors for the pathology.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
94

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started May 2025

Shorter than P25 for all trials

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 21, 2025

Completed
6 days until next milestone

Study Start

First participant enrolled

May 27, 2025

Completed
3 days until next milestone

First Posted

Study publicly available on registry

May 30, 2025

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2025

Completed
Last Updated

May 30, 2025

Status Verified

May 1, 2025

Enrollment Period

7 months

First QC Date

May 21, 2025

Last Update Submit

May 21, 2025

Conditions

Keywords

PTSDcomplex PTSDmilitary veteranemotional contagionoxytocinvasopressine

Outcome Measures

Primary Outcomes (1)

  • To characterize attachment styles within a military population by comparing a group of military personnel without PTSD (No-PTSD Group) with a group of military personnel with PTSD (PTSD Group).

    Our primary outcome measure involves a comparison of the proportions of individuals exhibiting a secure attachment style versus an insecure attachment style (including the subtypes anxious-avoidant, anxious-ambivalent, and disorganized) between the two groups.

    One visit study

Study Arms (2)

PTSD-group

military personnel or veterans suffering from PTSD

no PTSD-group

military on active duty without PTSD

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

No-PTSD Group: Military personnel without PTSD will be recruited from within an infantry regiment of the army. PTSD Group: Military personnel with PTSD will be recruited during workshops conducted by the CABAT (Cellule d'Aide aux Blessés de l'Armée de Terre - Army Wounded Support Unit) in 2025 and 2026.

You may qualify if:

  • Volunteers who agreed to participate in the study and provided written consent
  • Affiliated with social security
  • Proficient in the French language
  • Military personnel diagnosed with post-traumatic stress disorder related to their duties
  • Participants in activities offered by the wounded service support units

You may not qualify if:

  • Adults subject to a protective measure
  • Refusal to participate in the study
  • Unrectified Legionnaires

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Biospecimen

Retention: SAMPLES WITH DNA

Salivary samplings : (i) for the measurement of vasopressin and oxytocin levels , via saliva impregnation by leaving an absorbent (cylindrical cotton) in the mouth for 2 minutes without chewing, and (ii) and for the analysis of genetic polymorphisms, by collecting 2 ml of spit.

MeSH Terms

Conditions

Stress Disorders, Post-Traumatic

Condition Hierarchy (Ancestors)

Stress Disorders, TraumaticTrauma and Stressor Related DisordersMental Disorders

Study Officials

  • Anaïs Duffaud, PhD

    Institut de Recherche Biomédicale des Armées

    STUDY DIRECTOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 21, 2025

First Posted

May 30, 2025

Study Start

May 27, 2025

Primary Completion

December 31, 2025

Study Completion

December 31, 2025

Last Updated

May 30, 2025

Record last verified: 2025-05

Data Sharing

IPD Sharing
Will not share